Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (81-90 of 321) with videos related to

Pageof 33
Sort By:
Blood Cancer Journal|March 13, 2026
Cutaneous adverse events following CAR T-cell therapy in hematologic malignanciesElvira Umyarova, John Sharp, Charles Pei, et al.
Nephrology (Carlton, Vic.)|March 14, 2020
Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantationApoorva Anandan, Merle Kolk, Nicole Ferrari, et al.
Oncoimmunology|March 22, 2021
BAFF receptor antibody for mantle cell lymphoma therapyKeman Zhang, Nand K Roy, Yorleny Vicioso, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Blood Reviews|May 2, 2016
Myeloid-derived suppressor cells: The green light for myeloma immune escapeEhsan Malek, Marcos de Lima, John J Letterio, et al.
Bone Marrow Transplantation|July 25, 2018
Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agentsYi-Bin Chen, Philip L McCarthy, Theresa Hahn, et al.
Cancer|February 4, 2006
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaMuzaffar H Qazilbash, Rima Saliba, Marcos De Lima, et al.
Leukemia & Lymphoma|May 27, 2004
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myelomaMichele L Donato, Ana Aleman, Richard E Champlin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 15, 2014
Music therapy for patients who have undergone hematopoietic stem cell transplantChelsea G Ratcliff, Sarah Prinsloo, Michael Richardson, et al.
Cancer|June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicityElias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.
Pageof 33

Showing results (81-90 of 321) with videos related to

Sort By:
Pageof 33
Blood Cancer Journal|March 13, 2026
Cutaneous adverse events following CAR T-cell therapy in hematologic malignanciesElvira Umyarova, John Sharp, Charles Pei, et al.
Nephrology (Carlton, Vic.)|March 14, 2020
Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantationApoorva Anandan, Merle Kolk, Nicole Ferrari, et al.
Oncoimmunology|March 22, 2021
BAFF receptor antibody for mantle cell lymphoma therapyKeman Zhang, Nand K Roy, Yorleny Vicioso, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Blood Reviews|May 2, 2016
Myeloid-derived suppressor cells: The green light for myeloma immune escapeEhsan Malek, Marcos de Lima, John J Letterio, et al.
Bone Marrow Transplantation|July 25, 2018
Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agentsYi-Bin Chen, Philip L McCarthy, Theresa Hahn, et al.
Cancer|February 4, 2006
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myelomaMuzaffar H Qazilbash, Rima Saliba, Marcos De Lima, et al.
Leukemia & Lymphoma|May 27, 2004
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myelomaMichele L Donato, Ana Aleman, Richard E Champlin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 15, 2014
Music therapy for patients who have undergone hematopoietic stem cell transplantChelsea G Ratcliff, Sarah Prinsloo, Michael Richardson, et al.
Cancer|June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicityElias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.
Pageof 33